Allogene Therapeutics, Inc

(NASDAQ:ALLO)

Latest On Allogene Therapeutics, Inc (ALLO):

Date/Time Type Description Signal Details
2023-05-04 09:00 ESTNewsAllogene Therapeutics, Inc. (ALLO) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:00 ESTNewsAllogene Therapeutics, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-03 20:46 ESTNewsAllogene Therapeutics GAAP EPS of -$0.68 misses by $0.06, revenue of $0.05M beats by $0.04MN/A
2023-05-02 19:29 ESTNewsAllogene Therapeutics Q1 2023 Earnings PreviewN/A
2023-03-03 18:05 ESTNewsAllogene: ALLO-715 Phase 1 Results And ALLO-213 Preclinical Data Is PromisingN/A
2023-03-01 07:09 ESTNewsAllogene Therapeutics GAAP EPS of -$0.66 beats by $0.04, revenue of $0.05M misses by $0.01MN/A
2023-03-01 07:09 ESTNewsAllogene Therapeutics, Inc. (ALLO) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:16 ESTNewsAllogene Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-24 12:15 ESTNewsAllogene stock rises ~15% as JPMorgan upgrades on near-term catalystsN/A
2023-01-06 22:18 ESTNewsAllogene Therapeutics up 7% following upgrade from BairdN/A
2023-01-03 12:33 ESTNewsAllogene ends winning streak as R&D chief departsN/A
2022-12-13 02:21 ESTNewsAllogene down 11% following downgrade to underperform at BofAN/A
2022-12-02 18:35 ESTNewsAllogene: Pioneering Allogeneic CAR-T Developer With No Near-Term CatalystsN/A
2022-11-17 00:51 ESTNewsAllogene Therapeutics (ALLO) Investor presntation - SlideshowN/A
2022-11-03 05:19 ESTNewsAllogene Therapeutics GAAP EPS of -$0.58 beats by $0.06, revenue of $0.05M beats by $0.04MN/A
2022-11-03 05:19 ESTNewsAllogene Therapeutics, Inc. (ALLO) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 22:08 ESTNewsAllogene Therapeutics Q3 2022 Earnings PreviewN/A
2022-10-06 22:48 ESTNewsAllogene begins phase 2 allogeneic CAR T trial for large B-cell lymphoma candidateN/A
2022-09-21 21:21 ESTNewsAllogene slips as Servier exits partnership for CD19 productsN/A
2022-09-14 00:36 ESTNewsAllogene: Possible First Pivotal Study With Allogeneic CAR-T ALLO-501AN/A
2022-08-16 04:03 ESTNewsAllogene Therapeutics, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-11 05:48 ESTNewsAllogene stock rises on Q2 beat despite downgrade at Raymond James; eyes FDA nod for ALLO-501A trial in 'coming weeks'N/A
2022-08-10 12:06 ESTNewsAllogene Therapeutics, Inc.'s (ALLO) CEO David Chang on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 12:05 ESTNewsAllogene downgraded to market perform from outperform at Raymond JamesN/A
2022-08-09 18:14 ESTNewsAllogene Therapeutics GAAP EPS of -$0.52 beats by $0.08, revenue of $0.09M beats by $0.07MN/A
2022-08-08 18:26 ESTNewsAllogene Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-15 09:02 ESTNewsAllogene stock rises as Goldman ups rating to Buy on way forward for cancer programsN/A
2022-06-24 21:23 ESTNewsAllogene Therapeutics: Multibagger Potential, But Terribly RiskyN/A
2022-06-08 15:04 ESTNewsAllogene's ALLO-501A for lymphoma gets regenerative medicine advanced therapy designationN/A
2022-05-05 20:58 ESTNewsAllogene Therapeutics, Inc. (ALLO) CEO David Chang on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 22:11 ESTNewsAllogene Therapeutics GAAP EPS of -$0.56 beats by $0.02N/A
2022-05-04 03:01 ESTNewsAllogene Therapeutics Q1 2022 Earnings PreviewN/A
2022-04-27 18:19 ESTNewsAllogene multiple myeloma candidate granted Orphan Drug DesignationN/A
2022-04-14 19:02 ESTNewsAllogene Therapeutics opens new manufacturing site in CaliforniaN/A
2022-04-02 12:50 ESTNewsAllogene: Speculative CAR T Biotech With Big Potential In OncologyN/A
2022-04-01 18:50 ESTNewsAllogene: Leading The Allogeneic CAR-T Space, AgainN/A
2022-02-24 08:21 ESTNewsAllogene Therapeutics GAAP EPS of -$0.54 beats by $0.06, revenue of $51MN/A
2022-02-24 08:21 ESTNewsAllogene Therapeutics, Inc. (ALLO) CEO David Chang on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 08:21 ESTNewsAllogene Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-22 17:43 ESTNewsAllogene Therapeutics Q4 2021 Earnings PreviewN/A
2022-01-28 20:09 ESTNewsAllogene Therapeutics (ALLO) Investor Presentation (Slideshow)N/A
2022-01-12 18:10 ESTNewsAllogene: Lifting Of The Clinical Hold Will Be A Major BinaryN/A
2022-01-12 00:38 ESTNewsAllogene to work with Antion on miRNA technology for multiplex gene silencingN/A
2022-01-11 07:54 ESTNewsAllogene closes down 9% despite lifting of clinical hold; other gene editing names mixedN/A
2022-01-10 15:23 ESTNewsFDA removes clinical hold on Allogene's all AlloCAR T clinical trialsN/A
2021-12-15 05:33 ESTNewsAllogene Therapeutics (ALLO) Presents At 63rd Annual Meeting of ASH - SlideshowN/A
2021-11-12 16:26 ESTNewsWarning: ALLO is at high risk of performing badlyN/A
2021-11-05 00:41 ESTNewsAllogene Therapeutics EPS misses by $0.01N/A
2021-11-05 00:41 ESTNewsAllogene Therapeutics' (ALLO) CEO David Chang on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-20 02:12 ESTNewsRamifications Of Allogene's Clinical Hold: Possible Sector-Wide ImplicationsN/A

About Allogene Therapeutics, Inc (ALLO):

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A, which is in Phase I/II clinical trial for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for treating R/R multiple myeloma; ALLO-819, an allogeneic CAR T cell product candidates for the treatment of acute myeloid leukemia; ALLO-605, an allogeneic CAR T cell product candidate for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; and DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc., as well as clinical trial collaboration agreement with SpringWorks Therapeutics, Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates. The company was founded in 2017 and is headquartered in South San Francisco, California.

ALLO Quotes by TradingView

See Advanced Chart

General

  • Name Allogene Therapeutics, Inc
  • Symbol ALLO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 264
  • Fiscal Year EndDecember
  • IPO Date2018-10-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.allogene.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 4.86
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.19
  • Next Year EPS Estimate -$2.61
  • Next Quarter EPS Estimate -$0.56
  • Return on Assets -17%
  • Return on Equity -29%
  • Earnings Per Share -$2.07
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 5.14 billion
  • EBITDA -134911008
  • PE Ratio -1.95
  • Analyst Target Price $50.62
  • Book Value Per Share $7.69
View More

Share Statistics

  • Shares Outstanding 140.65 million
  • Shares Float 73.67 million
  • % Held by Insiders 3574%
  • % Held by Institutions 61.5%
  • Shares Short 11.55 million
  • Shares Short Prior Month 11.08 million
  • Short Ratio 14.39
  • Short % of Float 14%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.16
  • 52 Week High $55
  • 52 Week Low $17.79
  • 50 Day Moving Average 35.26
  • 200 Day Moving Average 33.35
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Allogene Therapeutics, Inc (ALLO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Allogene Therapeutics, Inc (ALLO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.53-$0.553.64%
2020-09-302020-11-04$N/A-$0.52-$0.556.12%
2020-06-302020-08-05$N/A-$0.53-$0.542.23%
2020-03-312020-05-06$N/A-$0.50-$0.5813.57%
2019-12-312020-02-27$N/A-$0.58-$0.6814.59%
2019-09-302019-11-05$N/A-$0.50-$0.547.92%
2019-06-302019-08-07$N/A-$0.41-$0.447.53%
2019-03-312019-05-07$N/A-$0.32-$0.4426.66%
2018-12-312019-03-08$N/A-$0.37-$0.25-45.67%
2018-09-302018-11-21$N/A-$0.43-$0.39-11.31%

Allogene Therapeutics, Inc (ALLO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Allogene Therapeutics, Inc (ALLO) Chart:

ALLO chart by TradingView

Allogene Therapeutics, Inc (ALLO) News:

Below you will find a list of latest news for Allogene Therapeutics, Inc (ALLO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Allogene Therapeutics, Inc (ALLO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-02-210.52.1CALL0 2263.79TRUE00
2025-02-2111.84CALL0 4259.16TRUE00
2025-02-211.51.25CALL0 1190.34TRUE00
2025-02-2121.15CALL0 9143.64TRUE00
2025-02-212.50.9CALL0 1518143.59TRUE00
2025-02-2150.4CALL0 770172.89FALSE00
2025-02-217.50.05CALL0 150FALSE00
2025-02-210.50PUT0 00FALSE00
2025-02-2110PUT0 00FALSE00
2025-02-211.50.15PUT0 63127.24FALSE00
2025-02-2120.3PUT0 20FALSE00
2025-02-212.50.63PUT0 1140FALSE00
2025-02-2152.4PUT0 24124.73TRUE00
2025-02-217.50PUT0 0135.43TRUE00
2025-05-162.51.3CALL0 2130.47TRUE00
2025-05-1650.6CALL0 70FALSE00
2025-05-167.50CALL0 00FALSE00
2025-05-162.50PUT0 0113.55FALSE00
2025-05-1652.65PUT0 5108.43TRUE00
2025-05-167.50PUT0 0102.71TRUE00

Latest ALLO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$8.845
Jun 13, 2022 7:59 PM EST5$8.845
Jun 13, 2022 7:59 PM EST4$8.845
Jun 13, 2022 7:59 PM EST20$8.84
Jun 13, 2022 7:59 PM EST47$8.85

Allogene Therapeutics, Inc (ALLO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000007800318000079/0000078003-18-000079-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000007800318000080/0000078003-18-000080-index.htm
2018-10-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737287/000007800318000083/0000078003-18-000083-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000090342318000545/0000903423-18-000545-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000090342318000546/0000903423-18-000546-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000090342318000561/0000903423-18-000561-index.htm
2018-10-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737287/000090342318000570/0000903423-18-000570-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737287/000110465919007969/0001104659-19-007969-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000114036119009199/0001140361-19-009199-index.htm
2019-05-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737287/000114036119009204/0001140361-19-009204-index.htm
2018-10-11424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1737287/000119312518297747/0001193125-18-297747-index.htm
2018-10-15POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1737287/000119312518299225/0001193125-18-299225-index.htm
2018-10-15POS462BPost-effective amendment to registration statement [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1737287/000119312518299286/0001193125-18-299286-index.htm
2018-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000119312518299356/0001193125-18-299356-index.htm
2018-10-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1737287/000119312518306372/0001193125-18-306372-index.htm
2018-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000119312518310633/0001193125-18-310633-index.htm
2018-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000119312518348919/0001193125-18-348919-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737287/000119312519038199/0001193125-19-038199-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737287/000119312519038201/0001193125-19-038201-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000119312519044774/0001193125-19-044774-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000119312519068107/0001193125-19-068107-index.htm
2019-03-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1737287/000119312519069173/0001193125-19-069173-index.htm
2019-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000119312519102909/0001193125-19-102909-index.htm
2019-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1737287/000119312519115774/0001193125-19-115774-index.htm
2019-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737287/000119312519115862/0001193125-19-115862-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000119312519139002/0001193125-19-139002-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000119312519169316/0001193125-19-169316-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737287/000119312520035541/0001193125-20-035541-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737287/000119312520035546/0001193125-20-035546-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118054733/0001209191-18-054733-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118054734/0001209191-18-054734-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118054735/0001209191-18-054735-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118054736/0001209191-18-054736-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118054737/0001209191-18-054737-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118054738/0001209191-18-054738-index.htm
2018-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118054739/0001209191-18-054739-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118055372/0001209191-18-055372-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118055374/0001209191-18-055374-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118055379/0001209191-18-055379-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118055385/0001209191-18-055385-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118055388/0001209191-18-055388-index.htm
2018-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919118055391/0001209191-18-055391-index.htm
2019-02-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119009724/0001209191-19-009724-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119019755/0001209191-19-019755-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119019758/0001209191-19-019758-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119019762/0001209191-19-019762-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119019767/0001209191-19-019767-index.htm
2019-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119026675/0001209191-19-026675-index.htm
2019-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119026676/0001209191-19-026676-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119030076/0001209191-19-030076-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119030079/0001209191-19-030079-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119034861/0001209191-19-034861-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119038862/0001209191-19-038862-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119038864/0001209191-19-038864-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119038866/0001209191-19-038866-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119038868/0001209191-19-038868-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119039728/0001209191-19-039728-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119041955/0001209191-19-041955-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119041957/0001209191-19-041957-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119042874/0001209191-19-042874-index.htm
2019-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119042877/0001209191-19-042877-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm
2019-09-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919005667/0001214659-19-005667-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919005669/0001214659-19-005669-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919005740/0001214659-19-005740-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919005741/0001214659-19-005741-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919006019/0001214659-19-006019-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919006021/0001214659-19-006021-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919006702/0001214659-19-006702-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919006703/0001214659-19-006703-index.htm
2019-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919007333/0001214659-19-007333-index.htm
2019-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465919007335/0001214659-19-007335-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920001733/0001214659-20-001733-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002528/0001214659-20-002528-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002530/0001214659-20-002530-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002734/0001214659-20-002734-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002735/0001214659-20-002735-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002736/0001214659-20-002736-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002803/0001214659-20-002803-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002804/0001214659-20-002804-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002805/0001214659-20-002805-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002806/0001214659-20-002806-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920002807/0001214659-20-002807-index.htm
2020-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920003629/0001214659-20-003629-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920003819/0001214659-20-003819-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920003820/0001214659-20-003820-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920005383/0001214659-20-005383-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920005493/0001214659-20-005493-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920005494/0001214659-20-005494-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920005495/0001214659-20-005495-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920005496/0001214659-20-005496-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920006805/0001214659-20-006805-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920007184/0001214659-20-007184-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920007671/0001214659-20-007671-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/0001214659-20-008039-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008375/0001214659-20-008375-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008504/0001214659-20-008504-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008506/0001214659-20-008506-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008508/0001214659-20-008508-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000138713120005509/0001387131-20-005509-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000138713120005745/0001387131-20-005745-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm
2020-07-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737287/000138713120006309/0001387131-20-006309-index.htm
2020-08-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1737287/000138713120007266/0001387131-20-007266-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1737287/000142284820000012/0001422848-20-000012-index.htm
2018-11-2110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737287/000156459018030022/0001564590-18-030022-index.htm
2019-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1737287/000156459019006991/0001564590-19-006991-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737287/000156459019016480/0001564590-19-016480-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728719000005/0001737287-19-000005-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737287/000173728719000008/0001737287-19-000008-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728719000016/0001737287-19-000016-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737287/000173728719000020/0001737287-19-000020-index.htm
2019-11-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1737287/000173728719000022/0001737287-19-000022-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728719000023/0001737287-19-000023-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728719000025/0001737287-19-000025-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000010/0001737287-20-000010-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1737287/000173728720000012/0001737287-20-000012-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000013/0001737287-20-000013-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000017/0001737287-20-000017-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000021/0001737287-20-000021-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000022/0001737287-20-000022-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000024/0001737287-20-000024-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737287/000173728720000027/0001737287-20-000027-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000029/0001737287-20-000029-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1737287/000173728720000032/0001737287-20-000032-index.htm
2020-06-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1737287/000173728720000036/0001737287-20-000036-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000039/0001737287-20-000039-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000041/0001737287-20-000041-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000045/0001737287-20-000045-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737287/000173728720000047/0001737287-20-000047-index.htm
2020-10-268-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000050/0001737287-20-000050-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1737287/000173728720000055/0001737287-20-000055-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1737287/000173728720000059/0001737287-20-000059-index.htm
2018-10-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1737287/999999999518002586/9999999995-18-002586-index.htm
2018-10-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1737287/999999999718008531/9999999997-18-008531-index.htm

Allogene Therapeutics, Inc (ALLO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allogene Therapeutics, Inc (ALLO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3574%
Institutional Ownership: 6150%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-05Joshua A KazamDirectorBuy9,969.001,033,305.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920005494/0001214659-20-005494-index.htm
2019-09-03Rafael AmadoEVP of R&D and CMOBuy105,162.00105,162.00https://www.sec.gov/Archives/edgar/data/1737287/000121465919005669/0001214659-19-005669-index.htm
2020-10-09ALISON MOOREChief Technical OfficerSell39,509.0041.001,619,869.00108,370.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm
2020-10-12ALISON MOOREChief Technical OfficerSell24,233.0042.001,017,786.00108,370.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm
2020-10-13ALISON MOOREChief Technical OfficerSell11,031.0042.00463,302.00108,370.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm
2020-10-07Rafael AmadoEVP of R&D and CMOSell16,538.0039.40651,514.51111,677.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008508/0001214659-20-008508-index.htm
2020-10-06ALISON MOOREChief Technical OfficerSell44,574.0040.001,782,960.00117,680.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008506/0001214659-20-008506-index.htm
2020-10-08ALISON MOOREChief Technical OfficerSell5,065.0041.00207,665.00117,680.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm
2020-10-13ALISON MOOREChief Technical OfficerBuy11,031.002.2725,040.37119,401.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm
2020-10-15ERIC THOMAS SCHMIDTChief Financial OfficerSell100.0043.014,301.001,197,595.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm
2020-10-15ERIC THOMAS SCHMIDTChief Financial OfficerSell2,099.0042.3288,839.551,197,695.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm
2020-10-15ERIC THOMAS SCHMIDTChief Financial OfficerSell3,479.0041.33143,799.591,199,794.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm
2020-10-15ERIC THOMAS SCHMIDTChief Financial OfficerSell4,218.0040.07169,010.621,203,273.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm
2020-10-15ERIC THOMAS SCHMIDTChief Financial OfficerSell5,104.0039.47201,441.611,207,491.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008703/0001214659-20-008703-index.htm
2019-06-06Franz B HumerDirectorBuy16,377.00121,247.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119038864/0001209191-19-038864-index.htm
2020-09-21ERIC THOMAS SCHMIDTChief Financial OfficerSell1,911.0037.0470,783.441,212,595.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/0001214659-20-008039-index.htm
2020-09-21ERIC THOMAS SCHMIDTChief Financial OfficerSell3,200.0035.96115,069.121,214,506.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/0001214659-20-008039-index.htm
2020-09-21ERIC THOMAS SCHMIDTChief Financial OfficerSell9,889.0034.76343,692.201,217,706.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008039/0001214659-20-008039-index.htm
2020-10-08ALISON MOOREChief Technical OfficerBuy5,065.002.2711,497.55122,745.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm
2020-08-13ALISON MOOREChief Technical OfficerBuy32,451.002.2773,663.77126,272.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920007184/0001214659-20-007184-index.htm
2020-10-01Rafael AmadoEVP of R&D and CMOSell9,752.0036.37354,661.71128,215.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008375/0001214659-20-008375-index.htm
2020-06-05Franz B HumerDirectorBuy9,969.00131,216.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920005495/0001214659-20-005495-index.htm
2020-10-12ALISON MOOREChief Technical OfficerBuy24,233.002.2755,008.91132,603.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008571/0001214659-20-008571-index.htm
2020-03-18Rafael AmadoEVP of R&D and CMOBuy30,800.00135,962.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920002804/0001214659-20-002804-index.htm
2019-06-06Joshua A KazamDirectorBuy16,377.001,407,028.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119038866/0001209191-19-038866-index.htm
2020-10-09ALISON MOOREChief Technical OfficerBuy30,199.002.2768,551.73147,879.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008532/0001214659-20-008532-index.htm
2019-03-13Arie BelldegrunDirectorBuy115,333.00150,333.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119019758/0001209191-19-019758-index.htm
2020-10-06ALISON MOOREChief Technical OfficerBuy35,264.002.2780,049.28161,536.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008506/0001214659-20-008506-index.htm
2020-06-04Arie BelldegrunDirectorBuy106,382.0047.004,999,954.001,798,163.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920005383/0001214659-20-005383-index.htm
2020-08-07TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell7,686.0037.70289,730.6918,716,306.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm
2020-08-07TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell5,605.0037.02207,505.5118,723,992.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm
2020-08-06TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell19,554.0037.33730,001.6618,729,597.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm
2020-08-06TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell4,600.0038.22175,792.6818,749,151.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120007268/0001387131-20-007268-index.htm
2020-06-30TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell59,747.0042.212,522,052.3119,716,306.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm
2020-06-29TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell24,904.0043.271,077,543.7819,776,053.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm
2020-06-26TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell500.0044.0122,005.0019,800,957.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120006093/0001387131-20-006093-index.htm
2020-06-25TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell72,359.0044.193,197,327.1319,801,457.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm
2020-06-24TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell15,269.0043.93670,713.7319,873,816.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm
2018-10-15OWEN N. WITTEDirectorBuy15,000.0018.00270,000.00198,750.00https://www.sec.gov/Archives/edgar/data/1737287/000120919118055388/0001209191-18-055388-index.htm
2020-06-23TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell22,213.0044.31984,235.8219,889,085.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm
2020-06-23TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell110,012.0043.914,830,373.8919,911,298.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005972/0001387131-20-005972-index.htm
2018-10-15David D ChangPresident and CEOBuy40,000.0018.00720,000.001,995,625.00https://www.sec.gov/Archives/edgar/data/1737287/000120919118055374/0001209191-18-055374-index.htm
2020-06-22TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell42,855.0043.161,849,827.5020,021,310.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm
2020-06-22TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell129,570.0042.725,534,893.5220,064,165.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm
2020-06-19TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell47,767.0042.042,008,306.1920,193,735.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm
2020-06-18TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell94,600.0042.143,986,595.3620,241,502.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005873/0001387131-20-005873-index.htm
2020-06-17TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell87,319.0042.183,683,482.1620,336,102.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005745/0001387131-20-005745-index.htm
2020-06-16TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell174,511.0042.207,364,678.3220,423,421.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005745/0001387131-20-005745-index.htm
2020-06-15TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell129,154.0042.145,442,885.3620,597,932.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005745/0001387131-20-005745-index.htm
2020-06-04TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell1,818.0047.1185,638.1620,727,086.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005509/0001387131-20-005509-index.htm
2020-06-03TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell274,080.0047.1312,916,814.8320,728,904.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005509/0001387131-20-005509-index.htm
2020-06-03TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell213,322.0047.7510,185,698.8621,002,984.00https://www.sec.gov/Archives/edgar/data/1737287/000138713120005509/0001387131-20-005509-index.htm
2019-05-14TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderSell1,918,755.0029.3856,373,021.9021,216,306.00https://www.sec.gov/Archives/edgar/data/1737287/000114036119009199/0001140361-19-009199-index.htm
2019-03-13David D ChangPresident and CEOBuy173,000.002,168,625.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119019755/0001209191-19-019755-index.htm
2018-10-15PFIZER INC10% Share HolderBuy55,556.0018.001,000,008.0022,032,040.00https://www.sec.gov/Archives/edgar/data/1737287/000007800318000080/0000078003-18-000080-index.htm
2020-03-16David D ChangPresident and CEOSell1,625.0020.0632,603.032,214,914.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920002734/0001214659-20-002734-index.htm
2020-03-16David D ChangPresident and CEOSell18,710.0019.24360,012.212,215,426.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920002734/0001214659-20-002734-index.htm
2018-10-15TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderBuy675,000.0018.0012,150,000.0023,135,061.00https://www.sec.gov/Archives/edgar/data/1737287/000090342318000561/0000903423-18-000561-index.htm
2020-06-05OWEN N. WITTEDirectorBuy9,969.00246,151.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920005496/0001214659-20-005496-index.htm
2018-10-15Franz B HumerDirectorBuy30,000.0018.00540,000.0030,000.00https://www.sec.gov/Archives/edgar/data/1737287/000120919118055385/0001209191-18-055385-index.htm
2018-10-15Arie BelldegrunDirectorBuy35,000.0018.00630,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1737287/000120919118055372/0001209191-18-055372-index.htm
2020-08-03Veer BhavnagriGeneral CounselSell16,450.0037.29613,397.47353,902.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920006805/0001214659-20-006805-index.htm
2020-09-01Veer BhavnagriGeneral CounselSell400.0035.8914,356.00353,902.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920007671/0001214659-20-007671-index.htm
2020-10-01Veer BhavnagriGeneral CounselSell800.0037.7330,180.00353,902.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm
2020-10-06Veer BhavnagriGeneral CounselSell10,000.0040.00400,000.00353,902.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008504/0001214659-20-008504-index.htm
2020-09-01Veer BhavnagriGeneral CounselSell24,600.0035.35869,610.00354,302.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920007671/0001214659-20-007671-index.htm
2020-10-01Veer BhavnagriGeneral CounselSell7,985.0037.03295,663.79354,702.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm
2020-10-01Veer BhavnagriGeneral CounselSell16,215.0036.21587,068.94362,687.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm
2020-10-06Veer BhavnagriGeneral CounselBuy10,000.002.2722,700.00363,902.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008504/0001214659-20-008504-index.htm
2020-08-03Veer BhavnagriGeneral CounselSell15,103.0036.46550,723.34370,352.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920006805/0001214659-20-006805-index.htm
2019-03-13ALISON MOOREChief Technical OfficerBuy37,050.0037,050.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119019767/0001209191-19-019767-index.htm
2019-06-03ALISON MOOREChief Technical OfficerSell1,623.0027.3144,319.1037,557.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119034861/0001209191-19-034861-index.htm
2020-09-01Veer BhavnagriGeneral CounselBuy25,000.002.2756,750.00378,902.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920007671/0001214659-20-007671-index.htm
2020-10-01Veer BhavnagriGeneral CounselBuy25,000.002.2756,750.00378,902.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920008378/0001214659-20-008378-index.htm
2020-08-03Veer BhavnagriGeneral CounselBuy25,000.002.2756,750.00385,455.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920006805/0001214659-20-006805-index.htm
2019-06-03ALISON MOOREChief Technical OfficerSell47,205.0026.741,262,455.2439,180.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119034861/0001209191-19-034861-index.htm
2020-06-04Arie BelldegrunDirectorBuy40,000.0047.001,880,000.0040,000.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920005383/0001214659-20-005383-index.htm
2020-03-16ERIC THOMAS SCHMIDTChief Financial OfficerSell5,150.0019.70101,432.8647,257.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920002735/0001214659-20-002735-index.htm
2020-03-16ERIC THOMAS SCHMIDTChief Financial OfficerSell300.0020.256,075.0047,906.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920002735/0001214659-20-002735-index.htm
2019-03-13ERIC THOMAS SCHMIDTChief Financial OfficerBuy49,400.0049,400.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119019762/0001209191-19-019762-index.htm
2020-03-16ALISON MOOREChief Technical OfficerSell3,750.0019.1971,980.1363,021.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920002736/0001214659-20-002736-index.htm
2019-06-28ALISON MOOREChief Technical OfficerBuy27,816.002.2763,142.3265,373.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119039728/0001209191-19-039728-index.htm
2019-07-26ALISON MOOREChief Technical OfficerSell13,193.0029.18384,994.1765,373.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm
2019-07-29ALISON MOOREChief Technical OfficerSell23,815.0029.39699,870.4665,373.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm
2019-07-30ALISON MOOREChief Technical OfficerSell11,819.0029.85352,738.0665,373.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm
2019-09-16ALISON MOOREChief Technical OfficerSell5,257.0032.00168,233.9966,067.00https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm
2019-09-17ALISON MOOREChief Technical OfficerSell22,503.0032.11722,560.0866,067.00https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm
2019-09-18ALISON MOOREChief Technical OfficerSell21,067.0032.13676,872.1866,067.00https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm
2019-09-16ALISON MOOREChief Technical OfficerBuy5,257.002.2711,933.3971,324.00https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm
2019-07-30ALISON MOOREChief Technical OfficerBuy11,819.002.2726,829.1377,192.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm
2019-07-26ALISON MOOREChief Technical OfficerBuy13,193.002.2729,948.1178,566.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm
2020-03-18ERIC THOMAS SCHMIDTChief Financial OfficerBuy30,800.0078,706.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920002803/0001214659-20-002803-index.htm
2019-06-03ALISON MOOREChief Technical OfficerBuy48,828.002.27110,839.5686,385.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119034861/0001209191-19-034861-index.htm
2019-09-18ALISON MOOREChief Technical OfficerBuy21,067.002.2747,822.0987,134.00https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm
2019-09-17ALISON MOOREChief Technical OfficerBuy22,503.002.2751,081.8188,570.00https://www.sec.gov/Archives/edgar/data/1737287/000121465919005941/0001214659-19-005941-index.htm
2019-07-29ALISON MOOREChief Technical OfficerBuy23,815.002.2754,060.0589,188.00https://www.sec.gov/Archives/edgar/data/1737287/000120919119043755/0001209191-19-043755-index.htm
2020-03-18ALISON MOOREChief Technical OfficerBuy30,800.0093,821.00https://www.sec.gov/Archives/edgar/data/1737287/000121465920002805/0001214659-20-002805-index.htm